LP
BNTX icon

LMR Partners’s BioNTech BNTX Stock Holding History

LMR Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,100
Closed -$771K – 1483
2025
Q4 		$771K Hold
8,100
– – ﹤0.01% 1044
2025
Q3 		$799K Sell
8,100
-25,000
-76% -$2.67M ﹤0.01% 998
2025
Q2 		$3.52M Hold
33,100
– – 0.03% 537
2025
Q1 		$3.01M Buy
+33,100
New +$3.71M 0.03% 557

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LMR Partners's BNTX Position: Q1 2026 in Review

LMR Partners sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 21,449 shares — an estimated $2.04M sold.

LMR Partners first reported a position in BNTX in Q4 2021 and held it in 14 quarters. The position peaked at $16.3M in Q2 2023. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • LMR Partners reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • LMR Partners sold 21,449 BioNTech shares in Q1 2026, an estimated $2.04M.
  • LMR Partners first reported a position in BioNTech in Q4 2021 and held it in 14 quarters.
  • LMR Partners's BioNTech position peaked at $16.3M in Q2 2023.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.